550 related articles for article (PubMed ID: 16917878)
21. Esophagogastric metaplasia relates to nodal metastases in adenocarcinoma of esophagus and cardia.
Ruffato A; Mattioli S; Perrone O; Lugaresi M; Di Simone MP; D'Errico A; Malvi D; Aprile MR; Raulli G; Frassineti L
Ann Thorac Surg; 2013 Apr; 95(4):1147-53. PubMed ID: 23434259
[TBL] [Abstract][Full Text] [Related]
22. [A clinical study of thoracic-abdominal double-incision and two-field lymphadenectomy in treatment of esophagogastric junction cancer].
Xiong HC; Wu N; Chen JF; Zhang LJ; Ji JF; Yang Y
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1478-81. PubMed ID: 17785087
[TBL] [Abstract][Full Text] [Related]
23. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinoma of the gastric cardia: treatment via a left thoracoabdominal approach.
Lekakos LN; Triantafillopoulos JK; Milingos ND; Sfikakis PG
Am Surg; 2002 Jul; 68(7):584-90. PubMed ID: 12132737
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
26. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
[TBL] [Abstract][Full Text] [Related]
27. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
[TBL] [Abstract][Full Text] [Related]
28. Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach.
Nakane Y; Okamura S; Boku T; Okusa T; Tanaka K; Hioki K
Am Surg; 1993 Jul; 59(7):423-9. PubMed ID: 8323075
[TBL] [Abstract][Full Text] [Related]
29. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
30. Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.
Di Martino N; Izzo G; Cosenza A; Cerullo G; Torelli F; Monaco L; Basciotti A; del Genio A
Hepatogastroenterology; 2005; 52(64):1110-5. PubMed ID: 16001641
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
32. Adenocarcinoma of the esophagogastric junction in Japan.
Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
34. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
35. Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens CJ; Ten Kate FJ; Obertop H; Izbicki JR; van Lanschot JJ
Dis Esophagus; 2008; 21(6):488-95. PubMed ID: 18840133
[TBL] [Abstract][Full Text] [Related]
36. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
37. Lymph node metastasis and surgical management of gastric cancer invading the esophagus.
Yonemura Y; Tsugawa K; Fonseca L; Fushida S; Matsumoto H; Ninomiya I; Sugiyama K; Fujimura T; Nishimura G; Miwa K
Hepatogastroenterology; 1995 Feb; 42(1):37-42. PubMed ID: 7782032
[TBL] [Abstract][Full Text] [Related]
38. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
[TBL] [Abstract][Full Text] [Related]
39. [Barrett and stomach carcinoma: surgical guidelines].
Hölscher AH; Bollschweiler E; Beckurts KT; Schneider PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():304-11. PubMed ID: 9931630
[TBL] [Abstract][Full Text] [Related]
40. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Surgery; 2005 Feb; 137(2):165-71. PubMed ID: 15674196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
